Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 98737

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 07, 2026
Product types
Drug
Classifications
Class III
Statuses
Ongoing
Recalling firm wording
Water-Jel Technologies, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2%), NET WT 0.5 OZ (14 g), Distributed by: CVS PHarmacy, INc., One CVS Drive, Woonsocket, RI 02895. NDC 59898-950

D-0509-2026
Recall number
D-0509-2026
Initiated
April 07, 2026
Classification
Class III
Status
Ongoing
Quantity
31,488 tubes

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Failed PH Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed PH Specifications

Code information

Lots: A5014, A5018, A5019

Distribution pattern

Nationwide in the USA